APA (7th ed.) Citation

Wang, J., Sun, P., Zhang, F., Xu, Y., & Guo, S. Metabolic reprogramming signature predicts prognosis and immune landscape in small cell lung cancer: MOCS2 validation and implications for personalized therapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Wang, Junyan, Panpan Sun, Fan Zhang, Yu Xu, and Shenghu Guo. Metabolic Reprogramming Signature Predicts Prognosis and Immune Landscape in Small Cell Lung Cancer: MOCS2 Validation and Implications for Personalized Therapy. Frontiers Media S.A.

MLA (9th ed.) Citation

Wang, Junyan, et al. Metabolic Reprogramming Signature Predicts Prognosis and Immune Landscape in Small Cell Lung Cancer: MOCS2 Validation and Implications for Personalized Therapy. Frontiers Media S.A.